Strawberry Fields REIT (NYSE AMERICAN: STRW) announced it will report its first quarter 2026 financial results before the market opens on May 8, 2026, and will host a conference call and webcast at 12:00 p.m. Eastern Time the same day to discuss the results. Investors are invited to pre-register for the call to receive dial-in…
Forward Industries (NASDAQ: FWDI) was featured in a recent article that discussed its positioning as an easy way for investors to take advantage of current market prices and ride the long-term crypto wave. The publication reads, “Solana (SOL) is seen as one of the most performant cryptocurrencies, due to high transaction volumes, fast speeds, and very…
HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its collaboration with Mount Sinai aimed at advancing artificial intelligence-driven electrocardiogram technology. The publication indicates that the move, “highlights HeartBeam’s growing focus on artificial intelligence (‘AI’)-enabled analysis and reinforces the relevance of its technology as healthcare increasingly shifts toward data-driven, remote monitoring solutions. The announcement…
Versus Systems (NASDAQ: VS) is a technology company focused on enhancing the way audiences interact with content across digital and live environments. “The company’s platform enables brands, teams, and content creators to integrate interactive elements directly into their experiences, allowing users to participate in games and earn real-world rewards while engaging with media,” reads an article…
Micropolis AI Robotics (NYSE American: MCRP) announced it has signed an engineering and manufacturing agreement with DP World to support the development and deployment of a container ascending system aimed at improving efficiency and safety in logistics operations. The collaboration marks an expansion into maritime and industrial automation, positioning Micropolis alongside global infrastructure and technology…
ParaZero Technologies (NASDAQ: PRZO) announced it has signed a reseller agreement with Romania-based New Akord Security to market its DefendAir counter-drone system and provide training and local support, expanding its footprint across Europe and NATO-aligned markets. The agreement includes an initial demo kit purchase and planned live demonstration for Romanian defense officials at the BSDA…
Perpetuals.com (NASDAQ: PDC) announced the expansion of its BayesShield AI technology into healthcare with the launch of BayesShield Clinical, designed to identify physicians with the strongest diagnostic accuracy across specific case types. The platform applies the company’s statistical methodology, originally developed for financial markets, to reduce bias and improve clinical decision-making, with initial deployment supported through a partnership with the European Institute of Management to…
NRx Pharmaceuticals (NASDAQ: NRXP) announced it received a positive Discipline Review Letter from the FDA Office of Generic Drugs covering quality-related aspects of its ketamine ANDA, with only minor administrative updates requested. The company also reported a supportive meeting with FDA leadership aligned with federal priorities to accelerate treatments for severe mental illness, reinforcing expectations for…
Nutriband (NASDAQ: NTRB) announced that CEO and Co-Founder Gareth Sheridan appeared on the Jack Neel Podcast to discuss the opioid crisis and the company’s AVERSA(TM) abuse-deterrent transdermal technology. The episode outlines how AVERSA(TM) is designed to reduce misuse, diversion, and accidental exposure of high-risk drugs such as fentanyl, while maintaining patient access, and is supported by a broad…
SEGG Media (NASDAQ: SEGG, LTRYW) highlighted strong engagement from its subsidiary Quadrant following the April 9 release of a YouTube video featuring Formula 1 drivers Lando Norris and Carlos Sainz Jr., which has generated more than four million views, including one million within the first 24 hours. The campaign, celebrating 100 years of karting, also drove…
Solowin Holdings (NASDAQ: AXG) reported preliminary, unaudited results for the fiscal year ended March 31, 2026, highlighting revenue growth to between $27 million and $29 million, nearly ten times higher year over year, driven by expansion in digital asset tokenization, stablecoin infrastructure, and AI-powered services. The company reported a net loss of $11 million to $13 million amid…
Beeline Holdings (NASDAQ: BLNE) will host a stakeholder update call on its first-quarter 2026 results on Thursday, May 14, 2026, at 5 p.m. ET. The call will be led by Chief Executive Officer Nick Liuzza and Chief Financial Officer Chris Moe, who are expected to review the company’s performance and provide updates on ongoing initiatives. To view the full…
Dr. Christopher J. Schaber outlines strategies for navigating constrained funding environment Soligenix (NASDAQ: SNGX) CEO Dr. Christopher J. Schaber emphasized the importance of capital discipline in a Pharmaphorum analysis examining how biotech companies can succeed in today’s constrained funding environment, where even late-stage programs may struggle to secure investment. The article notes that strong science alone is no longer sufficient,…
Channelchek, a Noble Financial Group platform, highlights a changing investment landscape in 2025, where capital is increasingly rotating toward differentiated growth opportunities beyond crowded sectors. Within this environment, Enhanced Group Inc.—an emerging sports, media, and consumer health company—is pursuing a public market debut through a proposed business combination with A Paradise Acquisition Corp. (NASDAQ: APAD), positioning itself within…
NRx Pharmaceuticals (NASDAQ: NRXP) welcomed a newly signed Executive Order aimed at accelerating medical treatments for serious mental illness, including expanded access to psychedelic therapies and faster regulatory pathways. The order directs the FDA to issue priority vouchers for qualifying breakthrough therapies and encourages broader use of clinical trial data and real-world evidence, aligning with NRx’s…
This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising. Planet Ventures (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) announced it has adopted a Disclosure, Confidentiality and Insider Trading Policy to strengthen compliance with Canadian securities laws, prevent selective disclosure and ensure proper handling of material information, while also updating its Investment Policy to…
By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published via Clinical Leader Soligenix (NASDAQ: SNGX) is emphasizing the strategic importance of patient-centric drug development, as outlined by CEO Christopher J. Schaber in a Clinical Leader guest column, which explores how reformulating therapies can improve access, adherence, and real-world viability. Drawing on the company’s experience with SGX945, Schaber explains that…
Safe Pro Group (NASDAQ: SPAI) reported continued execution of its share repurchase program, with 400,000 shares repurchased as of April 17, 2026, representing approximately 3.5% of its public float under a $3.0 million authorization approved in December 2025. The company funded repurchases through operating cash flow and its strong balance sheet, which included $16.7 million in cash and no…
Amid increased demand for advanced collision-avoidance systems as rail networks grow more complex, Rail Vision’s (NASDAQ: RVSN) artificial-intelligence (“AI”)-powered electro-optical sensors are emerging as a direct technological response. “Rail Vision develops vision-based detection systems designed to improve railway safety and operational performance, offering real-time obstacle detection and situational awareness that align closely with evolving safety priorities across the…
Boca Raton, Florida-based LIXTE Biotechnology Holdings (NASDAQ: LIXT) spent 2025 expanding its presence across multiple segments of oncology innovation. “The company is best known for its clinical-stage pharmaceutical pipeline built around LB-100, a first-in-class inhibitor of protein phosphatase 2A (‘PP2A’),” a recent article reads. “Rather than replacing established cancer therapies, LB-100 is designed to enhance their effectiveness.…